Marcella Perez
Family Medicine · Morristown, NJNPI 1720474406
Payments from drug & device makers
Across 92 payments — averaging $19.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$361
- Braeburn Inc.$280
- Gilead$257
- Merck$214
- Johnson & Johnson$139
- GSK$110
- plus $460 from 16 others
What the payments were for
- Food & beverage$1,80799%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 20 | $361 |
| Braeburn Inc. | 11 | $280 |
| Gilead | 9 | $257 |
| Merck | 15 | $214 |
| Johnson & Johnson | 2 | $139 |
| GSK | 7 | $110 |
| Alkermes, Inc. | 5 | $93 |
| Pfizer | 4 | $62 |
| Hologic Sales And Service, LLC | 2 | $44 |
| Lilly USA, LLC | 2 | $37 |
| Indivior Inc. | 2 | $30 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| Exact Sciences | 1 | $26 |
| Novo Nordisk | 2 | $26 |
| Medtronic | 1 | $17 |
| Bayer | 1 | $16 |
| Viiv Healthcare Company | 1 | $15 |
| Phadia US Inc. | 1 | $15 |
| Amgen | 1 | $14 |
| IBSA Pharma Inc. | 1 | $13 |
| Smith+Nephew | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,822 in reported general payments places this provider in the 75th percentile of 2,084 family medicine providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 20 | $32,120 |
| JardianceEmpagliflozin | 13 | $22,085 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 12 | $2,590 |
| Atorvastatin Calcium | 96 | $781 |
| Fluticasone Propionate | 18 | $515 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 16 | $426 |
| Levothyroxine Sodium | 44 | $365 |
| Metformin Hcl | 39 | $323 |
| Rosuvastatin Calcium | 19 | $310 |
| Losartan Potassium | 23 | $275 |
| Omeprazole | 21 | $271 |
| Amlodipine Besylate | 56 | $205 |
| Glimepiride | 14 | $203 |
| Lisinopril | 27 | $131 |
| Meloxicam | 23 | $88 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $26 | $32,12020 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,084 family medicine providers in New Jersey.
Other family medicine in Morristown
- Howard HassmanClementon$47.1M
- Matthew HongNorth Cape May$15.3M
- Rubaba HussainClark$3.8M
- Gaurang BrahmbhattHoboken$2.6M
- Michael DobrowClifton$2.1M
- Mikhail VarshavskiChatham$1.4M
- Amit BhalodiaCamden$707K
- Jennifer AmicoNew Brunswick$627K
- Janet ColeFar Hills$466K
- Matthew PintoMarlton$239K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.